Literature DB >> 26309436

Study of Serum Hepcidin as a Potential Mediator of the Disrupted Iron Metabolism in Obese Adolescents.

Hayam K Nazif1, Azza Abd El-Shaheed2, Karima A I El-Shamy3, Manal A Mohsen2, Nevein N Fadl4, Rehab S I Moustafa5.   

Abstract

BACKGROUND & AIMS: The prevalence of obesity continues to rise in both developed and developing nations. An association between iron status and obesity has been described in children and adults. We aimed to study the relation between serum hepcidin level and both iron as well as high sensitive CRP status in obese adolescents. MATERIALS &
METHODS: This work was conducted on 80 adolescents aging 12-14 years old, divided into two equal groups; obese and non-obese. Anthropometric measurements, determination of haemoglobin, serum iron, total iron binding capacity (TIBC), transferrin saturation, serum ferritin, soluble serum transferrin receptor (sTfR), high sensitive CRP (hs -CRP) and serum hepcidin were performed.
RESULTS: Obese adolescents showed significantly lower levels of haemoglobin, serum iron, serum ferritin and transferrin saturation. Significant higher diastolic blood pressure, higher mean TIBC, sTfR, serum hepcidin and hs -CRP were also found. Serum hepcidin level correlated positively with BMI and hs- CRP, but negatively with iron level in obese group.
CONCLUSION: These data suggest that hepcidin is an important modulator of anemia in obese patients. Obesity can be considered as a low grade inflammatory state, that stimulates the production of inflammatory markers such as CRP which can up-regulate hepcidin synthesis.

Entities:  

Keywords:  Children; Hepcidin; Iron deficiency; Obesity

Year:  2015        PMID: 26309436      PMCID: PMC4538894     

Source DB:  PubMed          Journal:  Int J Health Sci (Qassim)        ISSN: 1658-3639


  16 in total

1.  New and old players in the hepcidin pathway.

Authors:  Clara Camaschella; Laura Silvestri
Journal:  Haematologica       Date:  2008-10       Impact factor: 9.941

2.  Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH.

Authors:  Soumeya Bekri; Philippe Gual; Rodolphe Anty; Nathalie Luciani; Monsef Dahman; Bala Ramesh; Antonio Iannelli; Aline Staccini-Myx; Dominique Casanova; Imed Ben Amor; Marie-Christine Saint-Paul; Pierre-Michel Huet; Jean-Louis Sadoul; Jean Gugenheim; Surjit Kaila S Srai; Albert Tran; Yannick Le Marchand-Brustel
Journal:  Gastroenterology       Date:  2006-09       Impact factor: 22.682

3.  LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity.

Authors:  A Krause; S Neitz; H J Mägert; A Schulz; W G Forssmann; P Schulz-Knappe; K Adermann
Journal:  FEBS Lett       Date:  2000-09-01       Impact factor: 4.124

Review 4.  Iron deficiency and obesity: the contribution of inflammation and diminished iron absorption.

Authors:  James P McClung; J Philip Karl
Journal:  Nutr Rev       Date:  2009-02       Impact factor: 7.110

5.  Overweight children have higher circulating hepcidin concentrations and lower iron status but have dietary iron intakes and bioavailability comparable with normal weight children.

Authors:  I Aeberli; R F Hurrell; M B Zimmermann
Journal:  Int J Obes (Lond)       Date:  2009-07-28       Impact factor: 5.095

Review 6.  Epidemic inflammation: pondering obesity.

Authors:  Carl Nathan
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

7.  Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1995

8.  IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin.

Authors:  Elizabeta Nemeth; Seth Rivera; Victoria Gabayan; Charlotte Keller; Sarah Taudorf; Bente K Pedersen; Tomas Ganz
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

9.  Overweight impairs efficacy of iron supplementation in iron-deficient South African children: a randomized controlled intervention.

Authors:  J Baumgartner; C M Smuts; I Aeberli; L Malan; H Tjalsma; M B Zimmermann
Journal:  Int J Obes (Lond)       Date:  2012-09-04       Impact factor: 5.095

10.  Obesity modulate serum hepcidin and treatment outcome of iron deficiency anemia in children: a case control study.

Authors:  Mohammed Sanad; Mohammed Osman; Amal Gharib
Journal:  Ital J Pediatr       Date:  2011-07-19       Impact factor: 2.638

View more
  6 in total

Review 1.  A review of iron studies in overweight and obese children and adolescents: a double burden in the young?

Authors:  Carol Hutchinson
Journal:  Eur J Nutr       Date:  2016-02-16       Impact factor: 5.614

2.  Serum Hepcidin and Soluble Transferrin Receptor in the Assessment of Iron Metabolism in Children on a Vegetarian Diet.

Authors:  Jadwiga Ambroszkiewicz; Witold Klemarczyk; Joanna Mazur; Joanna Gajewska; Grażyna Rowicka; Małgorzata Strucińska; Magdalena Chełchowska
Journal:  Biol Trace Elem Res       Date:  2017-03-24       Impact factor: 3.738

3.  Serum hepcidin and iron status parameters in pregnant women and the association with adverse maternal and fetal outcomes: a study protocol for a prospective cohort study.

Authors:  Gabriela Amstad Bencaiova; Deborah Ruth Vogt; Irene Hoesli
Journal:  BMJ Open       Date:  2019-11-06       Impact factor: 2.692

4.  Anthropometric Markers and Iron Status of 6-12-Year-Old Thai Children: Associations and Predictors.

Authors:  Orapa Suteerojntrakool; Tharida Khongcharoensombat; Sirinuch Chomtho; Chansuda Bongsebandhu-Phubhakdi; Therdpong Tempark; Mary Fewtrell
Journal:  J Nutr Metab       Date:  2021-04-13

5.  Higher Hepcidin Levels in Adolescents with Obesity Are Associated with Metabolic Syndrome Dyslipidemia and Visceral Fat.

Authors:  Reyna Rodríguez-Mortera; Russell Caccavello; Ricardo Hermo; María Eugenia Garay-Sevilla; Alejandro Gugliucci
Journal:  Antioxidants (Basel)       Date:  2021-05-09

6.  Ferroportin-Hepcidin Axis in Prepubertal Obese Children with Sufficient Daily Iron Intake.

Authors:  Joanna Gajewska; Jadwiga Ambroszkiewicz; Witold Klemarczyk; Ewa Głąb-Jabłońska; Halina Weker; Magdalena Chełchowska
Journal:  Int J Environ Res Public Health       Date:  2018-10-01       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.